Streetbeat News

Legal

ABUS

MRNA

Moderna Inc's stock fell by 2.32% due to a patent dispute with Arbutus Biopharma over mRNA technology used in its COVID vaccine. Despite a 36.54% decline over the past year, the stock showed some recovery with a 7.6% increase in the past month. Moderna faces challenges from declining COVID-19 vaccine demand but anticipates revenue growth in 2024 with a strong product pipeline. The company's stock may be nearing a Golden Cross, indicating potential upward momentum.

Portfolio Pulse from Surbhi Jain

April 04, 2024 | 1:34 pm

GSK

PFE

SNY

Sanofi SA (NASDAQ:SNY) has reached an agreement in principle to settle around 4,000 U.S. lawsuits related to the heartburn drug Zantac, excluding cases in Delaware. The settlement, terms of which are confidential, comes amid allegations that Zantac could cause cancer due to NDMA, a potential carcinogen. Sanofi maintains no liability admission. The settlement aims to resolve most pending cases, avoiding prolonged litigation costs. Despite this, Sanofi faces ongoing lawsuits in Delaware. In 2019, Sanofi recalled Zantac, and the FDA ordered its removal in 2020. Sanofi has since reintroduced Zantac with a new active ingredient, famotidine. GSK Plc (NYSE:GSK) and Pfizer Inc (NYSE:PFE) have not joined broader settlement efforts. SNY shares rose 1.02% in premarket trading.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 1:16 pm

AAPL

NVDA

TSLA

The article covers a range of topics from cryptocurrency trends, including Bitcoin's potential surge, to tech updates like iPhone 16 rumors and Tesla's EV developments. It also touches on US and world politics, market movements, and company-specific news such as Apple's stock sale by CEO Tim Cook and Nvidia's supplier investment in the US chip sector.

Portfolio Pulse from Akanksha Bakshi

April 04, 2024 | 1:11 pm

NKLA

Nikola Corporation (NASDAQ:NKLA) shares are up in premarket trading after a significant drop the previous day. The company announced it produced and wholesaled 43 and 40 Class 8 hydrogen fuel cell electric vehicles, respectively, in Q1 2024 for U.S. customers. Nikola also began returning BEV "2.0" trucks to customers. However, the company has not completed its quarterly review or financial statements for Q1 2024. Earlier, Nikola took legal action against EMBR Motors and individuals involved in a takeover attempt after selling them the Badger electric pickup truck assets.

Portfolio Pulse from Nabaparna Bhattacharya

April 04, 2024 | 1:08 pm

TWLO

Anson Funds, a significant stockholder of Twilio Inc. (TWLO), has influenced governance changes at Twilio, including the departure of director Byron Deeter and a proposal to declassify the Board. These changes follow Anson Funds' engagement with Twilio, aiming to address the company's underperformance and governance issues. Anson Funds plans to continue holding the Twilio Board accountable to protect stockholder interests, focusing on strategy, operations, governance, and capital allocation.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:07 pm

IYG

MA

V

XLF

Mastercard Inc (NYSE:MA) plans to increase its network assessment fee from 0.13% to 0.14%, effective April 15, adding an estimated $259.1 million in costs for retailers based on last year's transactions. This decision follows a $30 billion settlement with Visa Inc (NYSE:V) over swipe fees, intended to provide financial relief to retailers. Despite the settlement aimed at capping swipe fees to save retailers around $30 billion, many merchants plan to continue legal action against Visa and Mastercard for alleged collusion on credit card fees. Mastercard's stock has seen over a 31% increase in the last 12 months, and exposure to Mastercard can also be gained through IShares U.S. Financial Services ETF (NYSE:IYG) and SPDR Select Sector Fund – Financial (NYSE:XLF).

Portfolio Pulse from Anusuya Lahiri

April 04, 2024 | 12:57 pm

ABUS

MRNA

Arbutus Biopharma has received a favorable ruling in its ongoing patent infringement lawsuit against Moderna, concerning the composition and encapsulation of mRNA in lipid nanoparticles. The court's decision supports Arbutus's interpretations of the patent claims, which could impact Moderna's mRNA technology.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 12:42 pm

AAPL

NVDA

TSM

UMC

Taiwan's recent earthquake, the biggest since 1999, poses a significant risk to the global semiconductor supply chain, affecting major chipmakers like TSMC (OTC:TSM) and UMC (NYSE:UMC). Both companies halted operations for inspections, impacting the supply chain. TSMC, crucial for tech giants like Nvidia (NASDAQ:NVDA) and Apple (NASDAQ:AAPL), managed to evacuate safely and plans to resume production quickly. However, the event highlights the geopolitical and natural disaster risks of Taiwan's central role in chip manufacturing.

Portfolio Pulse from Upwallstreet

April 04, 2024 | 10:18 am

META

NFLX

Elon Musk criticized Meta Platforms Inc. (META) following a recent outage of Facebook, Instagram, and WhatsApp, attributing it to the company's alleged distraction with selling user data. This incident comes amid allegations and court filings accusing Meta of sharing user data with Netflix (NFLX) and other privacy concerns. Meta has denied these allegations.

Portfolio Pulse from Benzinga Neuro

April 04, 2024 | 9:32 am

GL

Globe Life refuted claims made by short seller Nate Koppikar, stating that the articles he referenced in his comments, which labeled the company as an attractive short, were inaccurate and misleading, according to Reuters.

Portfolio Pulse from Charles Gross

April 04, 2024 | 9:18 am